Effect of vaccination programmes on mortality burden among children and young adults in the Netherlands during the 20th century: a historical analysis

In the 20th century, childhood mortality decreased rapidly, and vaccination programmes are frequently suggested as a contributing factor. However, quantification of this contribution is subject to debate or absent. We present historical data from the Netherlands that allow us to quantify the reducti...

Full description

Saved in:
Bibliographic Details
Published inThe Lancet infectious diseases Vol. 16; no. 5; pp. 592 - 598
Main Authors van Wijhe, Maarten, McDonald, Scott A, de Melker, Hester E, Postma, Maarten J, Wallinga, Jacco
Format Journal Article
LanguageEnglish
Published United States Elsevier Ltd 01.05.2016
Elsevier Limited
Subjects
Online AccessGet full text
ISSN1473-3099
1474-4457
1474-4457
DOI10.1016/S1473-3099(16)00027-X

Cover

Abstract In the 20th century, childhood mortality decreased rapidly, and vaccination programmes are frequently suggested as a contributing factor. However, quantification of this contribution is subject to debate or absent. We present historical data from the Netherlands that allow us to quantify the reduction in childhood mortality burden for vaccine-preventable diseases in this period as a function of vaccination coverage. We retrieved cause-specific and age-specific historical mortality data from Statistics Netherlands from 1903 to 2012 (for Dutch birth cohorts born from 1903 to 1992), and data for vaccination coverage since the start of vaccination programmes from the Dutch Health Care Inspectorate and the Dutch National Institute for Public Health and the Environment. We also obtained birth and migration data from Statistics Netherlands. We used a restricted mean life-time method to estimate cause-specific mortality burden among children and young adults for each birth cohort as the years of life lost up to age 20 years, excluding migration as a variable because this did not affect the results. To correct for long-term trends, we calculated the cause-specific contribution to the total childhood mortality burden. In the prevaccination era, the contribution to mortality burden was fairly constant for diphtheria (1·4%), pertussis (3·8%), and tetanus (0·1%). Around the start of mass vaccinations, these contributions to the mortality burden decreased rapidly to near zero. We noted similar patterns for poliomyelitis, mumps, and rubella. The number of deaths due to measles around the start of vaccination in the Netherlands were too few to detect an accelerated rate of decrease after mass vaccinations were started. We estimate that mass vaccination programmes averted 148 000 years of life lost up to age 20 years (95% prediction interval 110 000–201 000) among children born before 1992. This corresponds to about 9000 deaths averted (6000–12 000). Our historical time series analysis of mortality and vaccination coverage shows a strong association between increasing vaccination coverage and diminishing contribution of vaccine-preventable diseases to overall mortality. This analysis provides further evidence that mass vaccination programmes contributed to lowering childhood mortality burden. Dutch Ministry of Health, Welfare and Sport.
AbstractList Summary Background In the 20th century, childhood mortality decreased rapidly, and vaccination programmes are frequently suggested as a contributing factor. However, quantification of this contribution is subject to debate or absent. We present historical data from the Netherlands that allow us to quantify the reduction in childhood mortality burden for vaccine-preventable diseases in this period as a function of vaccination coverage. Methods We retrieved cause-specific and age-specific historical mortality data from Statistics Netherlands from 1903 to 2012 (for Dutch birth cohorts born from 1903 to 1992), and data for vaccination coverage since the start of vaccination programmes from the Dutch Health Care Inspectorate and the Dutch National Institute for Public Health and the Environment. We also obtained birth and migration data from Statistics Netherlands. We used a restricted mean life-time method to estimate cause-specific mortality burden among children and young adults for each birth cohort as the years of life lost up to age 20 years, excluding migration as a variable because this did not affect the results. To correct for long-term trends, we calculated the cause-specific contribution to the total childhood mortality burden. Findings In the prevaccination era, the contribution to mortality burden was fairly constant for diphtheria (1·4%), pertussis (3·8%), and tetanus (0·1%). Around the start of mass vaccinations, these contributions to the mortality burden decreased rapidly to near zero. We noted similar patterns for poliomyelitis, mumps, and rubella. The number of deaths due to measles around the start of vaccination in the Netherlands were too few to detect an accelerated rate of decrease after mass vaccinations were started. We estimate that mass vaccination programmes averted 148 000 years of life lost up to age 20 years (95% prediction interval 110 000–201 000) among children born before 1992. This corresponds to about 9000 deaths averted (6000–12 000). Interpretation Our historical time series analysis of mortality and vaccination coverage shows a strong association between increasing vaccination coverage and diminishing contribution of vaccine-preventable diseases to overall mortality. This analysis provides further evidence that mass vaccination programmes contributed to lowering childhood mortality burden. Funding Dutch Ministry of Health, Welfare and Sport.
In the 20th century, childhood mortality decreased rapidly, and vaccination programmes are frequently suggested as a contributing factor. However, quantification of this contribution is subject to debate or absent. We present historical data from the Netherlands that allow us to quantify the reduction in childhood mortality burden for vaccine-preventable diseases in this period as a function of vaccination coverage.BACKGROUNDIn the 20th century, childhood mortality decreased rapidly, and vaccination programmes are frequently suggested as a contributing factor. However, quantification of this contribution is subject to debate or absent. We present historical data from the Netherlands that allow us to quantify the reduction in childhood mortality burden for vaccine-preventable diseases in this period as a function of vaccination coverage.We retrieved cause-specific and age-specific historical mortality data from Statistics Netherlands from 1903 to 2012 (for Dutch birth cohorts born from 1903 to 1992), and data for vaccination coverage since the start of vaccination programmes from the Dutch Health Care Inspectorate and the Dutch National Institute for Public Health and the Environment. We also obtained birth and migration data from Statistics Netherlands. We used a restricted mean life-time method to estimate cause-specific mortality burden among children and young adults for each birth cohort as the years of life lost up to age 20 years, excluding migration as a variable because this did not affect the results. To correct for long-term trends, we calculated the cause-specific contribution to the total childhood mortality burden.METHODSWe retrieved cause-specific and age-specific historical mortality data from Statistics Netherlands from 1903 to 2012 (for Dutch birth cohorts born from 1903 to 1992), and data for vaccination coverage since the start of vaccination programmes from the Dutch Health Care Inspectorate and the Dutch National Institute for Public Health and the Environment. We also obtained birth and migration data from Statistics Netherlands. We used a restricted mean life-time method to estimate cause-specific mortality burden among children and young adults for each birth cohort as the years of life lost up to age 20 years, excluding migration as a variable because this did not affect the results. To correct for long-term trends, we calculated the cause-specific contribution to the total childhood mortality burden.In the prevaccination era, the contribution to mortality burden was fairly constant for diphtheria (1·4%), pertussis (3·8%), and tetanus (0·1%). Around the start of mass vaccinations, these contributions to the mortality burden decreased rapidly to near zero. We noted similar patterns for poliomyelitis, mumps, and rubella. The number of deaths due to measles around the start of vaccination in the Netherlands were too few to detect an accelerated rate of decrease after mass vaccinations were started. We estimate that mass vaccination programmes averted 148 000 years of life lost up to age 20 years (95% prediction interval 110 000-201 000) among children born before 1992. This corresponds to about 9000 deaths averted (6000-12 000).FINDINGSIn the prevaccination era, the contribution to mortality burden was fairly constant for diphtheria (1·4%), pertussis (3·8%), and tetanus (0·1%). Around the start of mass vaccinations, these contributions to the mortality burden decreased rapidly to near zero. We noted similar patterns for poliomyelitis, mumps, and rubella. The number of deaths due to measles around the start of vaccination in the Netherlands were too few to detect an accelerated rate of decrease after mass vaccinations were started. We estimate that mass vaccination programmes averted 148 000 years of life lost up to age 20 years (95% prediction interval 110 000-201 000) among children born before 1992. This corresponds to about 9000 deaths averted (6000-12 000).Our historical time series analysis of mortality and vaccination coverage shows a strong association between increasing vaccination coverage and diminishing contribution of vaccine-preventable diseases to overall mortality. This analysis provides further evidence that mass vaccination programmes contributed to lowering childhood mortality burden.INTERPRETATIONOur historical time series analysis of mortality and vaccination coverage shows a strong association between increasing vaccination coverage and diminishing contribution of vaccine-preventable diseases to overall mortality. This analysis provides further evidence that mass vaccination programmes contributed to lowering childhood mortality burden.Dutch Ministry of Health, Welfare and Sport.FUNDINGDutch Ministry of Health, Welfare and Sport.
In the 20th century, childhood mortality decreased rapidly, and vaccination programmes are frequently suggested as a contributing factor. However, quantification of this contribution is subject to debate or absent. We present historical data from the Netherlands that allow us to quantify the reduction in childhood mortality burden for vaccine-preventable diseases in this period as a function of vaccination coverage. We retrieved cause-specific and age-specific historical mortality data from Statistics Netherlands from 1903 to 2012 (for Dutch birth cohorts born from 1903 to 1992), and data for vaccination coverage since the start of vaccination programmes from the Dutch Health Care Inspectorate and the Dutch National Institute for Public Health and the Environment. We also obtained birth and migration data from Statistics Netherlands. We used a restricted mean life-time method to estimate cause-specific mortality burden among children and young adults for each birth cohort as the years of life lost up to age 20 years, excluding migration as a variable because this did not affect the results. To correct for long-term trends, we calculated the cause-specific contribution to the total childhood mortality burden. In the prevaccination era, the contribution to mortality burden was fairly constant for diphtheria (1·4%), pertussis (3·8%), and tetanus (0·1%). Around the start of mass vaccinations, these contributions to the mortality burden decreased rapidly to near zero. We noted similar patterns for poliomyelitis, mumps, and rubella. The number of deaths due to measles around the start of vaccination in the Netherlands were too few to detect an accelerated rate of decrease after mass vaccinations were started. We estimate that mass vaccination programmes averted 148 000 years of life lost up to age 20 years (95% prediction interval 110 000–201 000) among children born before 1992. This corresponds to about 9000 deaths averted (6000–12 000). Our historical time series analysis of mortality and vaccination coverage shows a strong association between increasing vaccination coverage and diminishing contribution of vaccine-preventable diseases to overall mortality. This analysis provides further evidence that mass vaccination programmes contributed to lowering childhood mortality burden. Dutch Ministry of Health, Welfare and Sport.
In the 20th century, childhood mortality decreased rapidly, and vaccination programmes are frequently suggested as a contributing factor. However, quantification of this contribution is subject to debate or absent. We present historical data from the Netherlands that allow us to quantify the reduction in childhood mortality burden for vaccine-preventable diseases in this period as a function of vaccination coverage. Methods We retrieved cause-specific and age-specific historical mortality data from Statistics Netherlands from 1903 to 2012 (for Dutch birth cohorts born from 1903 to 1992), and data for vaccination coverage since the start of vaccination programmes from the Dutch Health Care Inspectorate and the Dutch National Institute for Public Health and the Environment. We also obtained birth and migration data from Statistics Netherlands. We used a restricted mean life-time method to estimate cause-specific mortality burden among children and young adults for each birth cohort as the years of life lost up to age 20 years, excluding migration as a variable because this did not affect the results. To correct for long-term trends, we calculated the cause-specific contribution to the total childhood mortality burden. Findings In the prevaccination era, the contribution to mortality burden was fairly constant for diphtheria (1·4%), pertussis (3·8%), and tetanus (0·1%). Around the start of mass vaccinations, these contributions to the mortality burden decreased rapidly to near zero. We noted similar patterns for poliomyelitis, mumps, and rubella. The number of deaths due to measles around the start of vaccination in the Netherlands were too few to detect an accelerated rate of decrease after mass vaccinations were started. We estimate that mass vaccination programmes averted 148 000 years of life lost up to age 20 years (95% prediction interval 110 000-201 000) among children born before 1992. This corresponds to about 9000 deaths averted (6000-12 000). Interpretation Our historical time series analysis of mortality and vaccination coverage shows a strong association between increasing vaccination coverage and diminishing contribution of vaccine-preventable diseases to overall mortality. This analysis provides further evidence that mass vaccination programmes contributed to lowering childhood mortality burden. Funding Dutch Ministry of Health, Welfare and Sport.
Author van Wijhe, Maarten
Postma, Maarten J
McDonald, Scott A
Wallinga, Jacco
de Melker, Hester E
Author_xml – sequence: 1
  givenname: Maarten
  surname: van Wijhe
  fullname: van Wijhe, Maarten
  email: maarten.van.wijhe@rivm.nl
  organization: Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands
– sequence: 2
  givenname: Scott A
  surname: McDonald
  fullname: McDonald, Scott A
  organization: Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands
– sequence: 3
  givenname: Hester E
  surname: de Melker
  fullname: de Melker, Hester E
  organization: Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands
– sequence: 4
  givenname: Maarten J
  surname: Postma
  fullname: Postma, Maarten J
  organization: Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, Netherlands
– sequence: 5
  givenname: Jacco
  surname: Wallinga
  fullname: Wallinga, Jacco
  organization: Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26873665$$D View this record in MEDLINE/PubMed
BookMark eNqNkc1u1TAQhSNURH_gEUCW2JRFwE4cO6EChKryI1WwAKTuLF970uuS2MV2KuVFeF4m97ZCuhIqmyQzOfN5fM5hseeDh6J4yuhLRpl49Y1xWZc17bpjJl5QSitZXjwoDrDNS84bubf53kr2i8OUrihlklH-qNivRCtrIZqD4vdZ34PJJPTkRhvjvM4ueHIdw2XU4wiJYDWGmPXg8kxWU7TgiR6DvyRm7QYbl9JbMocJW9pOQ07EeZLXQL4APuOAvxOxU3QoWNoVzWtiwOcpzq-JJmuXcojO6AFJepiTS4-Lh70eEjy5fR8VPz6cfT_9VJ5__fj59P15aRre5ZKLRrZQN0IYUwveVNJ2LbZWotWVbExtuLasqiUTfU97ScGI3rY1bfH-VvL6qDjecvHCvyZIWY0uGRhwZwhTUqxlsm24bDqUPt-RXoUp4r6oki3naGknUfXsVjWtRrDqOrpRx1ndOY6Ck63AxJBShF4Zlzem56jdoBhVS75qk69awlNYbfJVFzjd7EzfHXDf3LvtHKCZNw6iSsaBN2BdxPiVDe5ewtsdghmcX0L7CTOkv16oVCm6hSwMJjaEBfDm34D_WOAPuQTmDg
CODEN LANCAO
CitedBy_id crossref_primary_10_3390_vaccines9111290
crossref_primary_10_1016_j_vaccine_2018_12_024
crossref_primary_10_1017_ssh_2023_7
crossref_primary_10_1093_cid_ciw529
crossref_primary_10_1136_bmjopen_2023_072722
crossref_primary_10_3389_fimmu_2020_590780
crossref_primary_10_1016_j_vaccine_2024_126533
crossref_primary_10_1080_17441730_2023_2193077
crossref_primary_10_1186_s41118_021_00143_5
crossref_primary_10_1016_S2214_109X_16_30185_1
crossref_primary_10_1186_s12879_021_06559_w
crossref_primary_10_1007_s12445_016_0289_4
crossref_primary_10_1017_S0950268818000481
crossref_primary_10_1016_j_jval_2022_10_011
crossref_primary_10_1016_j_vaccine_2023_10_043
crossref_primary_10_1016_S0001_4079_19_30503_5
crossref_primary_10_1097_EDE_0000000000000778
crossref_primary_10_1007_s00431_021_03997_1
crossref_primary_10_1007_s12452_019_00183_6
crossref_primary_10_1016_j_puhe_2022_09_020
crossref_primary_10_1093_aje_kwy021
crossref_primary_10_1016_S0140_6736_20_32657_X
crossref_primary_10_2807_1560_7917_ES_2019_24_18_1800363
crossref_primary_10_1080_07853890_2019_1588470
crossref_primary_10_1142_S2382624X18500121
crossref_primary_10_7774_cevr_2017_6_1_22
crossref_primary_10_1111_jpet_12560
crossref_primary_10_3390_vaccines9020144
crossref_primary_10_2807_1560_7917_ES_2017_22_28_30571
crossref_primary_10_1016_j_vaccine_2020_06_061
crossref_primary_10_1016_j_rico_2023_100236
crossref_primary_10_1371_journal_pmed_1004166
crossref_primary_10_1001_jamanetworkopen_2024_60558
crossref_primary_10_3390_vaccines13030276
crossref_primary_10_1007_s00431_017_2885_0
crossref_primary_10_1016_S1473_3099_16_00060_8
crossref_primary_10_1051_medsci_20173302001
crossref_primary_10_1016_j_vaccine_2019_07_097
crossref_primary_10_1016_j_medmal_2017_01_001
crossref_primary_10_1080_00324728_2023_2243913
crossref_primary_10_1038_s41467_018_07515_0
crossref_primary_10_1098_rsos_230966
crossref_primary_10_1001_jamapediatrics_2018_2349
crossref_primary_10_1002_pds_4419
crossref_primary_10_1093_aje_kwac048
crossref_primary_10_1017_S0950268820002691
crossref_primary_10_1016_j_arcped_2020_06_009
crossref_primary_10_1093_phe_phaa005
crossref_primary_10_1093_phe_phaa008
crossref_primary_10_20304_humanitas_1058039
crossref_primary_10_1007_s10067_020_05059_7
crossref_primary_10_1126_science_aav1003
crossref_primary_10_1098_rspb_2023_0690
crossref_primary_10_1093_ofid_ofy137
crossref_primary_10_1371_journal_pone_0196906
crossref_primary_10_1136_archdischild_2017_313488
Cites_doi 10.1056/NEJMoa0706589
10.1098/rstb.2013.0433
10.1056/NEJMms1215400
10.1016/S0140-6736(94)92091-5
10.2105/AJPH.89.12.1883
10.1093/ije/dyt122
10.1007/BF01796912
10.1111/j.1467-842X.1998.tb01142.x
10.1016/S0277-9536(98)00060-4
10.1098/rspb.2013.2676
10.1136/bmj.h436
10.1001/jama.281.1.61
10.1016/j.vaccine.2009.12.022
10.3201/eid0707.017743
10.1098/rspb.2013.2438
10.1111/j.1467-842X.1998.tb01141.x
10.1002/sim.5903
10.4054/DemRes.2013.29.41
10.1093/ije/26.4.772
10.1038/35015561
10.1016/S0264-410X(02)00587-X
10.1001/jama.298.18.2155
10.1016/S0140-6736(86)92270-1
10.1016/S0140-6736(06)68848-X
10.1016/S0140-6736(04)17593-4
ContentType Journal Article
Copyright 2016 Elsevier Ltd
Elsevier Ltd
Copyright © 2016 Elsevier Ltd. All rights reserved.
Copyright Elsevier Limited May 2016
Copyright_xml – notice: 2016 Elsevier Ltd
– notice: Elsevier Ltd
– notice: Copyright © 2016 Elsevier Ltd. All rights reserved.
– notice: Copyright Elsevier Limited May 2016
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
0TZ
3V.
7QL
7RV
7U9
7X7
7XB
88E
8AO
8C1
8C2
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
BENPR
C1K
CCPQU
FYUFA
GHDGH
H94
K9.
KB0
M0S
M1P
M7N
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
DOI 10.1016/S1473-3099(16)00027-X
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Pharma and Biotech Premium PRO
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Nursing & Allied Health Database
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Lancet Titles
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Medical Database (ProQuest)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Nursing & Allied Health Premium
Proquest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Pharma and Biotech Premium PRO
ProQuest One Academic Middle East (New)
Lancet Titles
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Sustainability
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

Pharma and Biotech Premium PRO

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 1474-4457
EndPage 598
ExternalDocumentID 4036093051
26873665
10_1016_S1473_3099_16_00027_X
S147330991600027X
1_s2_0_S147330991600027X
Genre Historical Article
Journal Article
GeographicLocations Netherlands
GeographicLocations_xml – name: Netherlands
GrantInformation Dutch Ministry of Health, Welfare and Sport.
GroupedDBID ---
--K
--M
-RU
..I
.1-
.FO
0R~
123
1B1
1P~
1~5
29L
4.4
457
4G.
53G
5VS
6PF
7-5
71M
7RV
7X7
88E
8AO
8C1
8C2
8FI
8FJ
AAAJQ
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAMRU
AAQFI
AAQQT
AAQXK
AARKO
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABJNI
ABMAC
ABMZM
ABUWG
ABWVN
ACGFS
ACIEU
ACPRK
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADMUD
ADNMO
AEIPS
AEKER
AENEX
AEUPX
AEUYN
AEVXI
AFKRA
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGCQF
AGEKW
AGHFR
AGQPQ
AHMBA
AIGII
AIIUN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BENPR
BKEYQ
BKOJK
BNPGV
BPHCQ
BVXVI
CCPQU
CJTIS
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
FYUFA
G-Q
GBLVA
HF~
HMCUK
HVGLF
HZ~
IHE
J1W
KOM
M1P
M41
MO0
N9A
NAPCQ
O-L
O9-
OD-
OO.
OZT
P-8
P-9
P2P
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
R2-
ROL
RPZ
SDG
SEL
SES
SPCBC
SSH
SSI
SSZ
T5K
TLN
UKHRP
UV1
WOW
XBR
Z5R
3V.
AACTN
AAYOK
AFCTW
AFKWA
AJOXV
ALIPV
AMFUW
RIG
SDF
ABLVK
ABYKQ
AJBFU
ZA5
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
0TZ
7QL
7U9
7XB
8FK
C1K
H94
K9.
M7N
PKEHL
PQEST
PQUKI
7X8
ACLOT
~HD
ID FETCH-LOGICAL-c549t-46578e3566cc364527d98578b68a275c3c4ad123716ff0f70ec6fd8308873d743
IEDL.DBID 7X7
ISSN 1473-3099
1474-4457
IngestDate Sat Sep 27 20:12:39 EDT 2025
Sat Jul 26 01:03:15 EDT 2025
Thu Apr 03 07:00:05 EDT 2025
Tue Jul 01 01:42:49 EDT 2025
Thu Apr 24 23:04:18 EDT 2025
Fri Feb 23 02:26:57 EST 2024
Tue Feb 25 19:56:55 EST 2025
Tue Aug 26 17:35:16 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License Copyright © 2016 Elsevier Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c549t-46578e3566cc364527d98578b68a275c3c4ad123716ff0f70ec6fd8308873d743
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink http://www.thelancet.com/article/S147330991600027X/pdf
PMID 26873665
PQID 1784468797
PQPubID 44001
PageCount 7
ParticipantIDs proquest_miscellaneous_1817854759
proquest_journals_1784468797
pubmed_primary_26873665
crossref_citationtrail_10_1016_S1473_3099_16_00027_X
crossref_primary_10_1016_S1473_3099_16_00027_X
elsevier_sciencedirect_doi_10_1016_S1473_3099_16_00027_X
elsevier_clinicalkeyesjournals_1_s2_0_S147330991600027X
elsevier_clinicalkey_doi_10_1016_S1473_3099_16_00027_X
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-05-01
PublicationDateYYYYMMDD 2016-05-01
PublicationDate_xml – month: 05
  year: 2016
  text: 2016-05-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: London
PublicationTitle The Lancet infectious diseases
PublicationTitleAlternate Lancet Infect Dis
PublicationYear 2016
Publisher Elsevier Ltd
Elsevier Limited
Publisher_xml – name: Elsevier Ltd
– name: Elsevier Limited
References Dayan, Quinlisk, Parker (bib25) 2008; 358
Taylor, Lewis, Powles (bib16) 1998; 22
Oostvogel, van Wijngaarden, van der Avoort (bib27) 1994; 344
Breiman, Streatfield, Phelan, Shifa, Rashid, Yunus (bib3) 2004; 364
(bib7) 2011; 60
Andersen, Canudas-Romo, Keiding (bib13) 2013; 29
Wolleswinkel-van den Bosch, van Poppel, Tabeau, Mackenbach (bib18) 1998; 47
van Panhuis, Grefenstette, Jung (bib5) 2013; 369
Hinman, Orenstein, Schuchat (bib8) 2011; 60
Kata (bib9) 2010; 28
Mackenbach, Looman (bib17) 2013; 42
Crowcroft, Pebody (bib24) 2006; 367
Peltola, Karanko, Kurki (bib23) 1986; 1
Armstrong, Conn, Pinner (bib2) 1999; 281
DiLiberti, Jackson (bib10) 1999; 89
de Melker, van den Hof, Berbers, Conyn-van Spaendonck (bib21) 2003; 21
Taylor, Lewis, Powles (bib15) 1998; 22
Wolleswinkel-van den Bosch, Looman, Van Poppel, Mackenbach (bib14) 1997; 26
Merler, Ajelli (bib19) 2014; 281
Greenwood (bib6) 2014; 369
Janssen, Kunst (bib22) 2004; 82
Martinez-Bakker, Bakker, King, Rohani (bib20) 2014; 281
Andersen (bib12) 2013; 32
van den Hof, Meffre, Conyn-van Spaendonck, Woonink, de Melker, van Binnendijk (bib26) 2001; 7
McCarthy (bib28) 2015; 350
Wolleswinkel-van den Bosch, Van Poppel, Mackenbach (bib11) 1996; 12
Roush, Murphy (bib4) 2007; 298
Tuljapurkar, Li, Boe (bib1) 2000; 405
Wolleswinkel-van den Bosch (10.1016/S1473-3099(16)00027-X_bib11) 1996; 12
Dayan (10.1016/S1473-3099(16)00027-X_bib25) 2008; 358
Mackenbach (10.1016/S1473-3099(16)00027-X_bib17) 2013; 42
Andersen (10.1016/S1473-3099(16)00027-X_bib12) 2013; 32
Peltola (10.1016/S1473-3099(16)00027-X_bib23) 1986; 1
Taylor (10.1016/S1473-3099(16)00027-X_bib16) 1998; 22
(10.1016/S1473-3099(16)00027-X_bib7) 2011; 60
Hinman (10.1016/S1473-3099(16)00027-X_bib8) 2011; 60
Oostvogel (10.1016/S1473-3099(16)00027-X_bib27) 1994; 344
Crowcroft (10.1016/S1473-3099(16)00027-X_bib24) 2006; 367
Roush (10.1016/S1473-3099(16)00027-X_bib4) 2007; 298
Andersen (10.1016/S1473-3099(16)00027-X_bib13) 2013; 29
Wolleswinkel-van den Bosch (10.1016/S1473-3099(16)00027-X_bib14) 1997; 26
DiLiberti (10.1016/S1473-3099(16)00027-X_bib10) 1999; 89
Breiman (10.1016/S1473-3099(16)00027-X_bib3) 2004; 364
McCarthy (10.1016/S1473-3099(16)00027-X_bib28) 2015; 350
Armstrong (10.1016/S1473-3099(16)00027-X_bib2) 1999; 281
Janssen (10.1016/S1473-3099(16)00027-X_bib22) 2004; 82
Kata (10.1016/S1473-3099(16)00027-X_bib9) 2010; 28
Taylor (10.1016/S1473-3099(16)00027-X_bib15) 1998; 22
van Panhuis (10.1016/S1473-3099(16)00027-X_bib5) 2013; 369
Wolleswinkel-van den Bosch (10.1016/S1473-3099(16)00027-X_bib18) 1998; 47
Greenwood (10.1016/S1473-3099(16)00027-X_bib6) 2014; 369
van den Hof (10.1016/S1473-3099(16)00027-X_bib26) 2001; 7
Merler (10.1016/S1473-3099(16)00027-X_bib19) 2014; 281
Tuljapurkar (10.1016/S1473-3099(16)00027-X_bib1) 2000; 405
Martinez-Bakker (10.1016/S1473-3099(16)00027-X_bib20) 2014; 281
de Melker (10.1016/S1473-3099(16)00027-X_bib21) 2003; 21
26873664 - Lancet Infect Dis. 2016 May;16(5):516-518
References_xml – volume: 29
  start-page: 1127
  year: 2013
  end-page: 1152
  ident: bib13
  article-title: Cause-specific measure of life years lost
  publication-title: Demogr Res
– volume: 1
  start-page: 137
  year: 1986
  end-page: 139
  ident: bib23
  article-title: Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland
  publication-title: Lancet
– volume: 369
  start-page: 2152
  year: 2013
  end-page: 2158
  ident: bib5
  article-title: Contagious diseases in the United States from 1888 to the present
  publication-title: N Engl J Med
– volume: 89
  start-page: 1883
  year: 1999
  end-page: 1885
  ident: bib10
  article-title: Long-term trends in childhood infectious disease mortality rates
  publication-title: Am J Public Health
– volume: 7
  start-page: 593
  year: 2001
  end-page: 597
  ident: bib26
  article-title: Measles outbreak in a community with very low vaccine coverage, the Netherlands
  publication-title: Emerg Infect Dis
– volume: 60
  start-page: 49
  year: 2011
  end-page: 57
  ident: bib8
  article-title: Vaccine-preventable diseases, immunizations, and MMWR–1961–2011
  publication-title: MMWR Surveill Summ
– volume: 405
  start-page: 789
  year: 2000
  end-page: 792
  ident: bib1
  article-title: A universal pattern of mortality decline in the G7 countries
  publication-title: Nature
– volume: 369
  start-page: 20130433
  year: 2014
  ident: bib6
  article-title: The contribution of vaccination to global health: past, present and future
  publication-title: Philos Trans R Soc Lond B Biol Sci
– volume: 42
  start-page: 1100
  year: 2013
  end-page: 1110
  ident: bib17
  article-title: Life expectancy and national income in Europe, 1900-2008: an update of Preston's analysis
  publication-title: Int J Epidemiol
– volume: 22
  start-page: 27
  year: 1998
  end-page: 36
  ident: bib16
  article-title: The Australian mortality decline: all-cause mortality 1788–1990
  publication-title: Aust N Z J Public Health
– volume: 281
  start-page: 61
  year: 1999
  end-page: 66
  ident: bib2
  article-title: Trends in infectious disease mortality in the United States during the 20th century
  publication-title: JAMA
– volume: 298
  start-page: 2155
  year: 2007
  end-page: 2163
  ident: bib4
  article-title: Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States
  publication-title: JAMA
– volume: 22
  start-page: 37
  year: 1998
  end-page: 44
  ident: bib15
  article-title: The Australian mortality decline: cause-specific mortality 1907–1990
  publication-title: Aust N Z J Public Health
– volume: 350
  start-page: h436
  year: 2015
  ident: bib28
  article-title: Measles outbreak linked to Disney theme parks reaches five states and Mexico
  publication-title: BMJ
– volume: 12
  start-page: 327
  year: 1996
  end-page: 361
  ident: bib11
  article-title: Reclassifying the causes of death to study the epidemiological transition in the Netherlands, 1875–1992
  publication-title: Eur J Popul
– volume: 60
  start-page: 814
  year: 2011
  end-page: 818
  ident: bib7
  article-title: Ten great public health achievements—worldwide, 2001–2010
  publication-title: MMWR Morb Mortal Wkly Rep
– volume: 47
  start-page: 429
  year: 1998
  end-page: 443
  ident: bib18
  article-title: Mortality decline in the Netherlands in the period 1850–1992: a turning point analysis
  publication-title: Soc Sci Med
– volume: 82
  start-page: 904
  year: 2004
  end-page: 913
  ident: bib22
  article-title: ICD coding changes and discontinuities in trends in cause-specific mortality in six European countries, 1950–99
  publication-title: Bull World Health Organ
– volume: 344
  start-page: 665
  year: 1994
  end-page: 670
  ident: bib27
  article-title: Poliomyelitis outbreak in an unvaccinated community in the Netherlands, 1992–93
  publication-title: Lancet
– volume: 26
  start-page: 772
  year: 1997
  end-page: 781
  ident: bib14
  article-title: Cause-specific mortality trends in the Netherlands, 1875–1992: a formal analysis of the epidemiologic transition
  publication-title: Int J Epidemiol
– volume: 281
  start-page: 20132676
  year: 2014
  ident: bib19
  article-title: Deciphering the relative weights of demographic transition and vaccination in the decrease of measles incidence in Italy
  publication-title: Proc Biol Sci
– volume: 281
  start-page: 20132438
  year: 2014
  ident: bib20
  article-title: Human birth seasonality: latitudinal gradient and interplay with childhood disease dynamics
  publication-title: Proc Biol Sci
– volume: 21
  start-page: 716
  year: 2003
  end-page: 720
  ident: bib21
  article-title: Evaluation of the national immunisation programme in the Netherlands: immunity to diphtheria, tetanus, poliomyelitis, measles, mumps, rubella and
  publication-title: Vaccine
– volume: 358
  start-page: 1580
  year: 2008
  end-page: 1589
  ident: bib25
  article-title: Recent resurgence of mumps in the United States
  publication-title: N Engl J Med
– volume: 364
  start-page: 2204
  year: 2004
  end-page: 2211
  ident: bib3
  article-title: Effect of infant immunisation on childhood mortality in rural Bangladesh: analysis of health and demographic surveillance data
  publication-title: Lancet
– volume: 28
  start-page: 1709
  year: 2010
  end-page: 1716
  ident: bib9
  article-title: A postmodern Pandora's box: anti-vaccination misinformation on the Internet
  publication-title: Vaccine
– volume: 32
  start-page: 5278
  year: 2013
  end-page: 5285
  ident: bib12
  article-title: Decomposition of number of life years lost according to causes of death
  publication-title: Stat Med
– volume: 367
  start-page: 1926
  year: 2006
  end-page: 1936
  ident: bib24
  article-title: Recent developments in pertussis
  publication-title: Lancet
– volume: 358
  start-page: 1580
  year: 2008
  ident: 10.1016/S1473-3099(16)00027-X_bib25
  article-title: Recent resurgence of mumps in the United States
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0706589
– volume: 369
  start-page: 20130433
  year: 2014
  ident: 10.1016/S1473-3099(16)00027-X_bib6
  article-title: The contribution of vaccination to global health: past, present and future
  publication-title: Philos Trans R Soc Lond B Biol Sci
  doi: 10.1098/rstb.2013.0433
– volume: 369
  start-page: 2152
  year: 2013
  ident: 10.1016/S1473-3099(16)00027-X_bib5
  article-title: Contagious diseases in the United States from 1888 to the present
  publication-title: N Engl J Med
  doi: 10.1056/NEJMms1215400
– volume: 344
  start-page: 665
  year: 1994
  ident: 10.1016/S1473-3099(16)00027-X_bib27
  article-title: Poliomyelitis outbreak in an unvaccinated community in the Netherlands, 1992–93
  publication-title: Lancet
  doi: 10.1016/S0140-6736(94)92091-5
– volume: 89
  start-page: 1883
  year: 1999
  ident: 10.1016/S1473-3099(16)00027-X_bib10
  article-title: Long-term trends in childhood infectious disease mortality rates
  publication-title: Am J Public Health
  doi: 10.2105/AJPH.89.12.1883
– volume: 42
  start-page: 1100
  year: 2013
  ident: 10.1016/S1473-3099(16)00027-X_bib17
  article-title: Life expectancy and national income in Europe, 1900-2008: an update of Preston's analysis
  publication-title: Int J Epidemiol
  doi: 10.1093/ije/dyt122
– volume: 60
  start-page: 49
  issue: suppl 4
  year: 2011
  ident: 10.1016/S1473-3099(16)00027-X_bib8
  article-title: Vaccine-preventable diseases, immunizations, and MMWR–1961–2011
  publication-title: MMWR Surveill Summ
– volume: 12
  start-page: 327
  year: 1996
  ident: 10.1016/S1473-3099(16)00027-X_bib11
  article-title: Reclassifying the causes of death to study the epidemiological transition in the Netherlands, 1875–1992
  publication-title: Eur J Popul
  doi: 10.1007/BF01796912
– volume: 22
  start-page: 37
  year: 1998
  ident: 10.1016/S1473-3099(16)00027-X_bib15
  article-title: The Australian mortality decline: cause-specific mortality 1907–1990
  publication-title: Aust N Z J Public Health
  doi: 10.1111/j.1467-842X.1998.tb01142.x
– volume: 82
  start-page: 904
  year: 2004
  ident: 10.1016/S1473-3099(16)00027-X_bib22
  article-title: ICD coding changes and discontinuities in trends in cause-specific mortality in six European countries, 1950–99
  publication-title: Bull World Health Organ
– volume: 47
  start-page: 429
  year: 1998
  ident: 10.1016/S1473-3099(16)00027-X_bib18
  article-title: Mortality decline in the Netherlands in the period 1850–1992: a turning point analysis
  publication-title: Soc Sci Med
  doi: 10.1016/S0277-9536(98)00060-4
– volume: 281
  start-page: 20132676
  year: 2014
  ident: 10.1016/S1473-3099(16)00027-X_bib19
  article-title: Deciphering the relative weights of demographic transition and vaccination in the decrease of measles incidence in Italy
  publication-title: Proc Biol Sci
  doi: 10.1098/rspb.2013.2676
– volume: 350
  start-page: h436
  year: 2015
  ident: 10.1016/S1473-3099(16)00027-X_bib28
  article-title: Measles outbreak linked to Disney theme parks reaches five states and Mexico
  publication-title: BMJ
  doi: 10.1136/bmj.h436
– volume: 281
  start-page: 61
  year: 1999
  ident: 10.1016/S1473-3099(16)00027-X_bib2
  article-title: Trends in infectious disease mortality in the United States during the 20th century
  publication-title: JAMA
  doi: 10.1001/jama.281.1.61
– volume: 28
  start-page: 1709
  year: 2010
  ident: 10.1016/S1473-3099(16)00027-X_bib9
  article-title: A postmodern Pandora's box: anti-vaccination misinformation on the Internet
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2009.12.022
– volume: 7
  start-page: 593
  issue: suppl 3
  year: 2001
  ident: 10.1016/S1473-3099(16)00027-X_bib26
  article-title: Measles outbreak in a community with very low vaccine coverage, the Netherlands
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid0707.017743
– volume: 281
  start-page: 20132438
  year: 2014
  ident: 10.1016/S1473-3099(16)00027-X_bib20
  article-title: Human birth seasonality: latitudinal gradient and interplay with childhood disease dynamics
  publication-title: Proc Biol Sci
  doi: 10.1098/rspb.2013.2438
– volume: 22
  start-page: 27
  year: 1998
  ident: 10.1016/S1473-3099(16)00027-X_bib16
  article-title: The Australian mortality decline: all-cause mortality 1788–1990
  publication-title: Aust N Z J Public Health
  doi: 10.1111/j.1467-842X.1998.tb01141.x
– volume: 32
  start-page: 5278
  year: 2013
  ident: 10.1016/S1473-3099(16)00027-X_bib12
  article-title: Decomposition of number of life years lost according to causes of death
  publication-title: Stat Med
  doi: 10.1002/sim.5903
– volume: 29
  start-page: 1127
  year: 2013
  ident: 10.1016/S1473-3099(16)00027-X_bib13
  article-title: Cause-specific measure of life years lost
  publication-title: Demogr Res
  doi: 10.4054/DemRes.2013.29.41
– volume: 26
  start-page: 772
  year: 1997
  ident: 10.1016/S1473-3099(16)00027-X_bib14
  article-title: Cause-specific mortality trends in the Netherlands, 1875–1992: a formal analysis of the epidemiologic transition
  publication-title: Int J Epidemiol
  doi: 10.1093/ije/26.4.772
– volume: 405
  start-page: 789
  year: 2000
  ident: 10.1016/S1473-3099(16)00027-X_bib1
  article-title: A universal pattern of mortality decline in the G7 countries
  publication-title: Nature
  doi: 10.1038/35015561
– volume: 21
  start-page: 716
  year: 2003
  ident: 10.1016/S1473-3099(16)00027-X_bib21
  article-title: Evaluation of the national immunisation programme in the Netherlands: immunity to diphtheria, tetanus, poliomyelitis, measles, mumps, rubella and Haemophilus influenzae type b
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(02)00587-X
– volume: 298
  start-page: 2155
  year: 2007
  ident: 10.1016/S1473-3099(16)00027-X_bib4
  article-title: Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States
  publication-title: JAMA
  doi: 10.1001/jama.298.18.2155
– volume: 60
  start-page: 814
  year: 2011
  ident: 10.1016/S1473-3099(16)00027-X_bib7
  article-title: Ten great public health achievements—worldwide, 2001–2010
  publication-title: MMWR Morb Mortal Wkly Rep
– volume: 1
  start-page: 137
  year: 1986
  ident: 10.1016/S1473-3099(16)00027-X_bib23
  article-title: Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland
  publication-title: Lancet
  doi: 10.1016/S0140-6736(86)92270-1
– volume: 367
  start-page: 1926
  year: 2006
  ident: 10.1016/S1473-3099(16)00027-X_bib24
  article-title: Recent developments in pertussis
  publication-title: Lancet
  doi: 10.1016/S0140-6736(06)68848-X
– volume: 364
  start-page: 2204
  year: 2004
  ident: 10.1016/S1473-3099(16)00027-X_bib3
  article-title: Effect of infant immunisation on childhood mortality in rural Bangladesh: analysis of health and demographic surveillance data
  publication-title: Lancet
  doi: 10.1016/S0140-6736(04)17593-4
– reference: 26873664 - Lancet Infect Dis. 2016 May;16(5):516-518
SSID ssj0017104
Score 2.455032
Snippet In the 20th century, childhood mortality decreased rapidly, and vaccination programmes are frequently suggested as a contributing factor. However,...
Summary Background In the 20th century, childhood mortality decreased rapidly, and vaccination programmes are frequently suggested as a contributing factor....
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 592
SubjectTerms Adolescent
Child
Child, Preschool
Communicable Diseases - history
Communicable Diseases - mortality
Diphtheria - mortality
History, 20th Century
History, 21st Century
Humans
Immunization
Immunization Programs - history
Infant
Infectious Disease
Infectious diseases
Mass Vaccination - history
Mass Vaccination - methods
Mass Vaccination - statistics & numerical data
Measles-Mumps-Rubella Vaccine
Mortality
Mumps
Netherlands
Public health
Smallpox
Vaccines
Whooping Cough - mortality
Young Adult
Young adults
Title Effect of vaccination programmes on mortality burden among children and young adults in the Netherlands during the 20th century: a historical analysis
URI https://www.clinicalkey.com/#!/content/1-s2.0-S147330991600027X
https://www.clinicalkey.es/playcontent/1-s2.0-S147330991600027X
https://dx.doi.org/10.1016/S1473-3099(16)00027-X
https://www.ncbi.nlm.nih.gov/pubmed/26873665
https://www.proquest.com/docview/1784468797
https://www.proquest.com/docview/1817854759
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1baxUxEA7agghFtN5OW8sIPuhD7G6ym83xRbS0FKFF1MK-hWySpYLd07qnQv-Iv7eTy6Y-WOvLwubk24Uzm5lvMpkZQl5JIXzwp6ddpSWtrO4oWkFBmXWWddJwXfls5MMjcXBcfWrrNm24jelY5aQTg6K2C-P3yHfKRqLnIpt58_7snPquUT66mlpo3CWrJTIR37qhabPDVaL1DFHlquGUIxW6zuDZ-ZoHX5fiTQjA0fYm23QT9ww2aP8heZDII3yI0n5E7rhhndw7TOHxdbIWN-Eg5hY9Jr9jbWJY9PBLG5wTxADpTNapGwHvTgMBRzIOXUhpgNB_CKYsb9CDhUuvEyDU6hjh-wDIGuGPVGGIyY5hmBXLEzDRlL0DDSe5Dgk-KRZAeUKO9_e-7R7Q1IiBGnQfl7QSuK4dR-ZnjA9bssbOJQ51QmrW1IabSls0geh79X3RN4UzoreSew3GLXKUp2RlWAzuOQFbd471HaoC5AWcFXPGOvR4WF_VJTe1nJFqEoEyqUq5b5bxQ-XjaF5yyktOlf5IHkpOtTPyNsPOYpmO2wBikq-aclBRayo0JLcBm78B3ZjW_qhKNTJVRLQHlyJAESkzMtGbSFv-56Vb0yeort-TV8SMvMw_o3bwIR89uMUFzpE4q_Y1HWfkWfx08__DEMuFqDf-_fBNch9JooiHPLfIyvLnhXuBRGzZbYfVhle5W26T1Y97R5-_XAGjNi0k
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB6VrQRICEH5WygwSCDBIe3GcRxvpQrx02pLuysErbQ3k9iOWolmC9mC-iI8Ds_WsZ2kHCjl0uN68zlSxp75xuOZAXguhXDBnzIqeC4jbvIiIisoImasYYXUSc5dNvJ4IkZ7_MM0nS7A7zYXxl2rbHWiV9Rmpt0Z-WqcSfJcZDbMXh99i1zXKBddbVto5E1rBbPuS4w1iR3b9uQnuXD1-tZ7kvcLxjY3dt-NoqbLQKTJN5pHXNCitQnRGq1dTI5lZihpqBAyZ1mqE81zQ_qdHIuyHJTZwGpRGpm47ZkYMsA07xVY5O4ApQeLbzcmHz91cQyy3z6uzbMkSoiMneUQrX7uBl_G4pUPAUbT86zjeezXW8HNW3Czoa_4Jqy327BgqyW4Om4C9EtwIxwDYshuugO_QnVknJX4g77eQTh7xOZW2KGtkX4deheA3AEsfFIF-g5I2OaZY14ZPHFaCX21kBoPKiTein8kK2NIt_TDbDDfRx2M6RrmuN9VQqGZQgmWu7B3KUK6B71qVtkHgCYtLCsLUkbETBI2GDJWkM_FSp7GiU5lH3grAqWbOumuXcdX1V2Ic5JTTnIqdpcCSXJq2oeVDnYUCoVcBBCtfFWbBUt6W5EpuwiY_Q1o60b71CpWNVODgHbgWHgoIWWHbAhWIE7_89Lldgmqs_d0e7IPz7q_ST-5oFNe2dkxPSPpqdRVlezD_bB0u-_DCJsIkT789-RP4dpod7yjdrYm24_gOlFWEa6cLkNv_v3YPiZaOC-eNHsP4ctlb_dTX7ZsFw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9RAFB5qC0UQ0XpbrXoEBX2YbjKTTGaFImq7tNYuRS3s25jMTGjBZqvZKv0j_ih_lWcuSX2w1pc-7my-CeTMuc25EfJUCuGCPzWtslLSzJQVRS0oKDPWsEpqXmauGnl3Irb2s3fTfLpAfnW1MC6tspOJXlCbmXZ35MO0kOi5yGJUDOuYFrG3MX51_JW6CVIu0tqN0yjjmAWz7tuNxSKPHXv6A925dn17A2n_jLHx5qe3WzROHKAa_aQ5zQQeYMvRxNHaxedYYUYSlyohS1bkmuusNCjr0cmo66QuEqtFbSR3rMoNKmPc9wpZKlDroyO49GZzsvehj2mgLvcx7qzglKNhdlZPNPzYLz5PxQsfDqTT8zTleZaw14jjG-R6NGXhdTh7N8mCbVbI8m4M1q-Qa-FKEEKl0y3yM3RKhlkN3_HrHYZ7SIgZYke2Bfx15N0BdA2g8gUW4KchQVdzDmVj4NRJKPCdQ1o4bABtWPijcBlC6aVfZsn8AHRQrC-hhIO-KwruFNqx3Cb7l0KkO2SxmTX2HgGTV5bVFQomtFI4S0aMVeh_sTrLU65zOSBZRwKlY890N7rji-qT4xzllKOcSl2CIFJOTQdkrYcdh6YhFwFER1_VVcSiDFeo1i4CFn8D2jZKolalqmUqCWgHToWHIlL2yGhsBSPqf1662h1Bdfaenj8H5En_N8oqF4AqGzs7wWckPpW7DpMDcjcc3f77MMRyIfL7_978MVlGtlfvtyc7D8hVtF5FyD5dJYvzbyf2IVqI8-pRZD0gny-b238DILhwWw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+vaccination+programmes+on+mortality+burden+among+children+and+young+adults+in+the+Netherlands+during+the+20th+century%3A+a+historical+analysis&rft.jtitle=The+Lancet+infectious+diseases&rft.au=van+Wijhe%2C+Maarten&rft.au=McDonald%2C+Scott+A&rft.au=de+Melker%2C+Hester+E&rft.au=Postma%2C+Maarten+J&rft.date=2016-05-01&rft.pub=Elsevier+Ltd&rft.issn=1473-3099&rft.eissn=1474-4457&rft.volume=16&rft.issue=5&rft.spage=592&rft.epage=598&rft_id=info:doi/10.1016%2FS1473-3099%2816%2900027-X&rft.externalDocID=S147330991600027X
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1473-3099&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1473-3099&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1473-3099&client=summon